A carregar...

Anti-Mullerian Hormone Levels are Lower in BRCA2 Mutation Carriers

OBJECTIVE: To compare Anti-Mullerian Hormone (AMH) levels in women at high risk for hereditary breast and ovarian cancer compared to healthy, low-risk controls. DESIGN: Prospective cohort SETTING: Ambulatory PATIENT(S): Reproductive age women with a uterus and both ovaries were analyzed in four grou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Fertil Steril
Main Authors: Johnson, Lauren, Sammel, Mary D., Domchek, Susan, Schanne, Allison, Prewitt, Maureen, Gracia, Clarisa
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5531590/
https://ncbi.nlm.nih.gov/pubmed/28476184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.fertnstert.2017.03.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!